Jürgen Burhenne

9.7k total citations
236 papers, 6.5k citations indexed

About

Jürgen Burhenne is a scholar working on Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jürgen Burhenne has authored 236 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 54 papers in Infectious Diseases and 47 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jürgen Burhenne's work include Pharmacogenetics and Drug Metabolism (52 papers), Pharmacological Effects and Toxicity Studies (40 papers) and Drug Transport and Resistance Mechanisms (38 papers). Jürgen Burhenne is often cited by papers focused on Pharmacogenetics and Drug Metabolism (52 papers), Pharmacological Effects and Toxicity Studies (40 papers) and Drug Transport and Resistance Mechanisms (38 papers). Jürgen Burhenne collaborates with scholars based in Germany, Sweden and United States. Jürgen Burhenne's co-authors include Walter E. Haefeli, Gerd Mikus, Johanna Weiß, Klaus‐Dieter Riedel, Michael Spiteller, I. Walter‐Sack, Jens Rengelshausen, K. Riedel, Kathrin I. Foerster and Eleni Aklillu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jürgen Burhenne

227 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jürgen Burhenne Germany	49	1.7k	1.3k	1.3k	1.1k	992	236	6.5k
Laurent A. Décosterd Switzerland	50	3.8k 2.3×	768 0.6×	1.8k 1.4×	1.5k 1.4×	1.6k 1.6×	270	10.1k
Daniel Abramowicz Belgium	60	642 0.4×	1.0k 0.8×	1.3k 1.1×	2.0k 1.8×	1.0k 1.0×	280	13.3k
Pieter Annaert Belgium	49	1.1k 0.7×	1.2k 1.0×	1.3k 1.1×	955 0.9×	1.9k 1.9×	237	7.6k
Mark A. Perazella United States	64	906 0.5×	957 0.8×	1.1k 0.9×	1.5k 1.3×	1.3k 1.3×	286	11.8k
Lena E. Friberg Sweden	45	533 0.3×	567 0.4×	1.1k 0.9×	1.4k 1.2×	1.8k 1.8×	215	6.8k
Uwe Christians United States	51	1.0k 0.6×	1.2k 1.0×	2.3k 1.8×	669 0.6×	1.6k 1.6×	360	10.9k
Peter J. Smith South Africa	40	2.0k 1.2×	899 0.7×	967 0.8×	931 0.8×	559 0.6×	147	5.3k
Alexander A. Vinks United States	48	767 0.5×	949 0.8×	678 0.5×	1.7k 1.6×	706 0.7×	288	8.5k
Uwe Fuhr Germany	47	503 0.3×	2.7k 2.1×	1.3k 1.1×	468 0.4×	1.6k 1.6×	199	6.9k
Kathrin Klein Germany	44	867 0.5×	3.6k 2.9×	1.8k 1.4×	508 0.5×	2.9k 2.9×	112	7.7k

Countries citing papers authored by Jürgen Burhenne

Since Specialization

Citations

This map shows the geographic impact of Jürgen Burhenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Burhenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Burhenne more than expected).

Fields of papers citing papers by Jürgen Burhenne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Burhenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Burhenne. The network helps show where Jürgen Burhenne may publish in the future.

Co-authorship network of co-authors of Jürgen Burhenne

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Burhenne. A scholar is included among the top collaborators of Jürgen Burhenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Burhenne. Jürgen Burhenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Recker, Mario, Mamadou Teketé, Taís Nóbrega de Sousa, et al.. (2025). Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa. Nature Communications. 16(1). 2680–2680.

Wintermark, Pia, Anie Lapointe, Gabriel Altit, et al.. (2025). Testing Higher Doses of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia: An Open-Label Dose-Finding Phase 1b Clinical Trial–Sildenafil Administration to Treat Neonatal Encephalopathy–Study 02. The Journal of Pediatrics. 285. 114701–114701. 1 indexed citations

Köberle, Beate, Sebastian Honnen, Jürgen Burhenne, et al.. (2024). RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans. Biomedicine & Pharmacotherapy. 173. 116450–116450. 1 indexed citations

Sauter, Max, Andreas D. Meid, Jürgen Burhenne, et al.. (2024). Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort. Clinical Pharmacology in Drug Development. 13(3). 297–306. 2 indexed citations

Chan, Kenneth Chun‐Ho, Nina Hofmann, Mareike Roscher, et al.. (2024). HGG-38. COMBINING TARGETED THERAPY AND RADIATION OUTPERFORMS SINGLE TREATMENTS IN PEDIATRIC HIGH-GRADE GLIOMA. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations

Burhenne, Jürgen, et al.. (2024). A Highly Sensitive UPLC-MS/MS Method for the Quantification of the Organic Cation Transporters’ Mediated Metformin Uptake and Its Inhibition in Cells. Molecules. 29(21). 5162–5162. 1 indexed citations

Burhenne, Jürgen, Johanna Weiß, Mathias Haag, et al.. (2023). Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology. 14. 1128547–1128547. 4 indexed citations

Haefeli, Walter E., et al.. (2022). Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. International Journal of Molecular Sciences. 23(7). 3637–3637. 10 indexed citations

Benzel, Julia, Philipp Uhl, Abigail Davis, et al.. (2021). Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification. Pharmaceutics. 13(9). 1498–1498. 3 indexed citations

10.

Fresnais, Margaux, Şevin Turcan, Dirk Theile, et al.. (2021). Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines. 10(1). 1–1. 10 indexed citations

11.

Longuespée, Rémi, Dirk Theile, Margaux Fresnais, et al.. (2020). Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. British Journal of Clinical Pharmacology. 87(3). 858–874. 13 indexed citations

12.

Lehmann, Marie‐Louise, Kathrin I. Foerster, Jürgen Burhenne, et al.. (2019). Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. British Journal of Clinical Pharmacology. 85(7). 1528–1537. 24 indexed citations

13.

Hohmann, Nicolas, Antje Blank, Jürgen Burhenne, et al.. (2019). Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses. British Journal of Clinical Pharmacology. 85(10). 2310–2320. 13 indexed citations

14.

Dalhoff, Kim, Tonny Studsgaard Petersen, Troels Riis, et al.. (2018). Higher chlorzoxazone clearance in obese children compared with nonobese peers. British Journal of Clinical Pharmacology. 84(8). 1738–1747. 16 indexed citations

15.

Foerster, Kathrin I., Andrea Huppertz, Oliver J. Müller, et al.. (2017). Simultaneous quantification of direct oral anticoagulants currently used in anticoagulation therapy. Journal of Pharmaceutical and Biomedical Analysis. 148. 238–244. 42 indexed citations

16.

Hohmann, Nicolas, Antje Blank, Johanna Weiß, et al.. (2017). Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics. British Journal of Clinical Pharmacology. 83(9). 1954–1965. 19 indexed citations

17.

Suzuki, Yosuke, et al.. (2016). Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing. Journal of Chromatography B. 1027. 207–213. 15 indexed citations

18.

Schmitt, Thomas, Regine Mayer‐Steinacker, Frank Mayer, et al.. (2016). Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO). European Journal of Cancer. 64. 74–82. 32 indexed citations

19.

Campos, Benito, Justo Lorenzo Bermejo, Ramadan Ali, et al.. (2011). Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas. American Journal Of Pathology. 178(5). 1953–1964. 57 indexed citations

20.

Burhenne, Jürgen, Claudia Röder, T. Heinrich, et al.. (2010). No Evidence for Induction of ABC Transporters in Peripheral Blood Mononuclear Cells in Humans after 14 Days of Efavirenz Treatment. Antimicrobial Agents and Chemotherapy. 54(10). 4185–4191. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact